Velesco doubles cGMP analytical lab space with facility purchase

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Nordroden)
(Image: Getty/Nordroden)

Related tags: Gmp, analytical, formulation, formulation lab, Developmental biology, Research and development, acquistion

Velesco Pharma has expanded its analytical research and development capabilities to meet a growing demand for its services after acquiring a new facility in Michigan.

With this acquisition, Velesco has doubled its formulation and analytical lab space. The development and clinical manufacturing company said the expansion will allow the company to maintain its rate of growth that it has experienced in recent years.

Gerry Cox, Velesco chief operating officer, told us, “Velesco Pharma has experienced increased demand for our analytical and formulation services in recent years and the time has come to create the capacity commensurate with this demand.”

Cox said the expansion will allow sponsors to advance new medicines into the clinic faster.

“Our new building in Wixom, MI was acquired earlier this year. The fit-out is nearing completion and our laboratory staff will be relocated to the expanded space prior to the end of the year,”​ said Cox.

According to a statement by Velesco’s CEO Dave Barnes, the company will be increasing its scientific team after this acquisition. The expansion will allow the company to meet the growing demand for formulation and analytical services.

The company will continue to offer research and current good manufacturing practice (cGMP) services during its move to the new laboratory. These services include formulation development, analytical method development and validation, release and stability testing, and clinical manufacturing.

Related news

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars